Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Chemosphere
|
November 26, 1998
Validation and application of a rapid in vitro assay for assessing the estrogenic potency of halogenated phenolic chemicals
W Körner, V Hanf, W Schuller, et al.
Arzneimittel-Forschung
|
January 1, 1982
Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration
A E Schindler, H M Bolt, M Zwirner, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
July 17, 2001
Regulation of estrogen receptor alpha and progesterone receptor (isoform A and B) expression in cultured human endometrial cells
J Prange-Kiel, G M Rune, M Zwirner, et al.
Maturitas
|
May 1, 1996
Serotonin metabolite excretion after postmenopausal estradiol therapy
T H Lippert, M Filshie, A O Mück, et al.
Cancer Detection and Prevention
|
January 1, 1985
Optimizing tumor markers in breast cancer: monitoring, prognosis, and therapy control
H J Staab, L M Ahlemann, F A Anderer, et al.
Archives of Gynecology and Obstetrics
|
January 1, 1993
Spontaneous and gonadotropin-releasing hormone induced human chorionic gonadotropin release from superfused JAR choriocarcinoma cells
T Ertl, A Török, J Bódis, et al.
Clinical and Experimental Obstetrics & Gynecology
|
January 1, 1996
Urinary excretion of relaxin after estradiol treatment of postmenopausal women
T H Lippert, F P Armbruster, H Seeger, et al.
Archives of Gynecology
|
January 1, 1983
Radioimmunoassay of 5 alpha-pregnane-3,20-dione. A metabolite of placental progesterone
M Zwirner, M M Fawzy, F C Bopp, et al.
American Journal of Surgery
|
October 23, 1997
High prevalence of bone disorders after gastrectomy
T T Zittel, B Zeeb, G W Maier, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 22, 2005
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use
M J Duffy, J M Bonfrer, J Kulpa, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Chemosphere
|
November 26, 1998
Validation and application of a rapid in vitro assay for assessing the estrogenic potency of halogenated phenolic chemicals
W Körner, V Hanf, W Schuller, et al.
Arzneimittel-Forschung
|
January 1, 1982
Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration
A E Schindler, H M Bolt, M Zwirner, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
July 17, 2001
Regulation of estrogen receptor alpha and progesterone receptor (isoform A and B) expression in cultured human endometrial cells
J Prange-Kiel, G M Rune, M Zwirner, et al.
Maturitas
|
May 1, 1996
Serotonin metabolite excretion after postmenopausal estradiol therapy
T H Lippert, M Filshie, A O Mück, et al.
Cancer Detection and Prevention
|
January 1, 1985
Optimizing tumor markers in breast cancer: monitoring, prognosis, and therapy control
H J Staab, L M Ahlemann, F A Anderer, et al.
Archives of Gynecology and Obstetrics
|
January 1, 1993
Spontaneous and gonadotropin-releasing hormone induced human chorionic gonadotropin release from superfused JAR choriocarcinoma cells
T Ertl, A Török, J Bódis, et al.
Clinical and Experimental Obstetrics & Gynecology
|
January 1, 1996
Urinary excretion of relaxin after estradiol treatment of postmenopausal women
T H Lippert, F P Armbruster, H Seeger, et al.
Archives of Gynecology
|
January 1, 1983
Radioimmunoassay of 5 alpha-pregnane-3,20-dione. A metabolite of placental progesterone
M Zwirner, M M Fawzy, F C Bopp, et al.
American Journal of Surgery
|
October 23, 1997
High prevalence of bone disorders after gastrectomy
T T Zittel, B Zeeb, G W Maier, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 22, 2005
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use
M J Duffy, J M Bonfrer, J Kulpa, et al.
Page
of 3